Skip to main content
Caplight Logo









3X4 Genetics

3X4 Genetics

Private
Bellevue, WashingtonHealthcare & Life Scienceshttps://3x4genetics.com/

Last Round

Series A

Dec 12, 2019

Total Funding Raised

$2.5M

Company Overview

3X4 Genetics is a health technology company that provides a genetics-based health assessment platform using a DNA test to offer personalized wellness insights.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Healthcare Analytics, Patient Engagement

Business Model

B2B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

genetic testingnutrigenomicsnutrigeneticspersonalized nutritionDNA analysispractitioner platformfunctional medicinegenetic reportpathway analysisintegrative medicineprecision medicineB2B2C healthcareAI health analyticsbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

3X4 Genetics Comparables

Compare 3X4 Genetics with similar companies based on industry and business-model similarity.

3X4 Genetics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The DNA Company
87%
Nutrigenomix
84%
IntellxxDNA
84%

3X4 Genetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 12, 2019
AngelJan 1, 2018

Key People

Founding team and executive leadership

Tony Hsu

Chief Executive Officer

Executive Team

3X4 Genetics Investors

Notable investors and investment history

3X4 Genetics investors
InvestorRounds
Alethea Capital Management, LLCSeries A
HAVAÍCSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors increased 42% MoM to 69.7K.

  • Jun 6, 2025

    Grew 15% QoQ, from 33 to 38 employees.

3X4 Genetics Filings

Explore SEC and related filing metadata, where available.

3X4 Genetics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 3X4 Genetics's valuation, stock price, and market status.

Is 3X4 Genetics a public or private company?

3X4 Genetics is a private company.

What is the current stock price of 3X4 Genetics?

3X4 Genetics is a private company with no public stock price. No recent secondary market data is available.

How much is 3X4 Genetics worth (valuation)?

Valuation information for 3X4 Genetics is not publicly available.

Can I buy 3X4 Genetics stock?

3X4 Genetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 3X4 Genetics's last funding round?

3X4 Genetics's most recent funding round was Series A on December 12, 2019.

Who are the main investors in 3X4 Genetics?

Key investors in 3X4 Genetics include Alethea Capital Management, LLC.

Will 3X4 Genetics IPO soon?

No public IPO plans have been announced for 3X4 Genetics.

How can I track 3X4 Genetics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 3X4 Genetics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBellevue, Washington
Employee Range29
Year Founded2018
Last FundingDec 12, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?